SCHEMBL14097679

SCHEMBL14097679

CCNC(=O)Nc1nc2cc(-c3ccccc3)ccc2o1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABL1 P00519 4/20 0.59
▸ GAA P10253 1/20 0.50
▸ L3MBTL1 Q9Y468 1/20 0.50
▸ HDAC6 Q9UBN7 3/20 0.48
▸ LIPG Q9Y5X9 1/20 0.46
▸ DGAT1 O75907 1/20 0.46
▸ RAB9A P51151 3/20 0.46
▸ CETP P11597 1/20 0.45
▸ AGPAT2 O15120 1/20 0.45
▸ HDAC3 O15379 1/20 0.45
▸ HDAC4 P56524 1/20 0.45
▸ HDAC1 Q13547 1/20 0.45
▸ HDAC7 Q8WUI4 1/20 0.45
▸ HDAC2 Q92769 1/20 0.45
▸ HDAC10 Q969S8 1/20 0.45
▸ HDAC11 Q96DB2 1/20 0.45
▸ HDAC8 Q9BY41 1/20 0.45
▸ HDAC9 Q9UKV0 1/20 0.45
▸ HDAC5 Q9UQL6 1/20 0.45
▸ FAAH O00519 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14097682 0.88 ABL1 (0.60) ABL1HDAC6RAB9ANPC1SMN1; SMN2
SCHEMBL14097700 0.85 GAA (0.50) ABL1GAAL3MBTL1HDAC6LIPG
SCHEMBL14097688 0.84 ABL1 (0.49) ABL1HDAC6RAB9ACETPHDAC1
SCHEMBL14097706 0.83 ABL1 (0.49) ABL1PIK3CA
SCHEMBL14097676 0.82 SMN1; SMN2 (0.58) GAAL3MBTL1HDAC6DGAT1RAB9A
SCHEMBL14097711 0.81 ABL1 (0.49) ABL1L3MBTL1RAB9ANPC1SMN1; SMN2
SCHEMBL14395652 0.81 GAA (0.48) GAAL3MBTL1HDAC6LIPGDGAT1
SCHEMBL14097701 0.80 ABL1 (0.48) ABL1RAB9ANPC1SMN1; SMN2KDM4E
SCHEMBL14097709 0.77 PIK3CA (0.53) ABL1HDAC6PIK3CA
SCHEMBL14395422 0.76 ABL1 (0.47) ABL1GAAL3MBTL1RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7414046-B2 Gyrase inhibitors and uses thereof VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-08-19 — — US disclosed
US-7414046-B2 Gyrase inhibitors and uses thereof VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-08-19 — — US disclosed
US-RE40245-E1 Gyrase inhibitors and uses thereof VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-04-15 — — US disclosed
US-RE40245-E1 Gyrase inhibitors and uses thereof VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-04-15 — — US disclosed
EP-1341769-B1 BACTERIAL GYRASE INHIBITORS AND USES THEREOF VERTEX PHARMA (US) 2007-10-17 — — EP disclosed
Send feedback